Answers are grounded in this paper and cite their sources.
The use of Fe3+ salts to saturate apotransferrin in buffer solutions and serum is often found in basic research and clinical procedures, despite a lack of adequate documentation. We have investigated the reaction of Fe3+ salts with apotransferrin using the absorption peak of Fe3+-transferrin at 470 nm to monitor the reaction. While titration of apo-transferrin with Fe3+-nitrilotriacetic acid gives a linear function and clear end point, titration with FeCl3 results in a sigmoidal-shaped curve and no clear end point is reached. The spectral data indicate that only 5 to 25% of the iron becomes bound when 1 eq of FeCl3 is added to apotransferrin at neutral pH. The remaining sites of the protein are vacant and available for reaction with Fe3+-nitrilotriacetic acid. Several methods for separating unbound FeCl3 from transferrin were attempted. They were, however, all unsuccessful and often gave misleading results. A stoichiometric reaction of Fe3+ salts with apotransferrin is only obtained when the reactants are initially mixed at a low pH and then carefully adjusted to neutrality. A method is also described for obtaining fully saturated, chelate-free Fe3+-transferrin, using Fe3+-nitrilotriacetic acid as the iron reagent. In view of the poor reactivity of Fe3+ salts with apotransferrin at neutral pH, proton release studies have been re-examined with Fe3+-nitrilotriacetic acid. A value close to 2.6 H+ released per Fe3+ bound was obtained by two methods.
No takes yet. Share an insight, caveat, or question.
Bates et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: